Charles River Laboratories

CRL

New York Stock Exchange. Currency in USD

208.90 -6.40 ( -2.89% )

Real time prices: December 06

Market Cap.
10.63B
Beta (5Y monthly)
1.28
Price/Earnings
21.26
EPS (TTM)
10.64
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
672,626
1y Target Est.
269.25
Day's Range
213.51
-
220.93
52 Week's Range
181.36
-
379.65

Historical Summary

Performance
EPS growth
Share Buybacks

About Charles River Laboratories

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.criver.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
50.46M
Employees
18600
Address
251 Ballardvale Street, Wilmington, MA, United States, 01887
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Latest news

Wall Street Breakfast: What Moved Markets
Wall Street Breakfast: What Moved Markets

Listen on the go! A daily podcast of Wall Street Breakfast will be available this...
By Seeking Alpha - 3 days ago

Analyst Ratings for Charles River
Analyst Ratings for Charles River

Over the past 3 months, 5 analysts have published their opinion on Charles River (NYSE:CRL)...
By Benzinga - 4 weeks ago

Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday...
By Benzinga - 4 weeks ago

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points....
By Benzinga - 4 weeks ago

Why Charles River Laboratories Stock Is Jumping Today
Why Charles River Laboratories Stock Is Jumping Today

Investors liked the company's Q3 update.
By The Motley Fool - 4 weeks ago

Charles River (CRL) Q3 Earnings Top Estimates, Margins Dip
Charles River (CRL) Q3 Earnings Top Estimates, Margins Dip

Headwinds associated with foreign exchange due to the strengthening of the U.S. dollar and interest...
By Zacks Investment Research - 4 weeks ago